Objectives: To continuously assess overall quality of life (QOL) and disease progression in patients with amyotrophic lateral sclerosis (ALS) at different stages of the disease and compare the results between these two variables.
INTRODUCTION

A
MYOTROPHIC LATERAL SCLEROSIS (ALS) is a devastating neurodegenerative disorder characterized by degeneration of motor neurons in the motor cortex, the brain stem, and the spinal cord. The disorder is relentlessly progressive and death usually results from respiratory failure within 3-5 years after onset. 1 The hereditary form of ALS (FALS) represents 5%-10% of all cases whereas the rest is considered to be sporadic. The cause of sporadic ALS is still unknown and there is no curative treatment. The only drug approved for the treatment of ALS is riluzole, a glutamate antagonist, which in clinical trials has prolonged life by an average of 2-3 months. [2] [3] [4] The optimal approach to the evaluation of quality of life (QOL) in people with ALS is still unclear. Health-related generic scales such as the SIP/ALS 19 and SF-36 have the advantage of enabling comparisons with other disorders, but do not consider specific issues affecting perception of QOL in ALS. The disease-specific scales ALSAQ-40 and ALSAQ-5 evaluate aspects of health considered to be important to patients with ALS, but do not allow comparisons with other disorders. QOL evaluated with health-related instruments has been shown to relate to the decline in motor function. [5] [6] [7] The nature of ques-tions in health-related QOL instruments may influence the responses obtained. A distinction should be made between health-related QOL, which reflects the health status of a patient and can be measured by instruments that focus on physical health and overall functional ability, and overall QOL, which take into account other nonmedical factors. 8 QOL evaluated by the McGill Quality of Life Questionnaire (MQOL), 9 which is less heavily weighted against physical function, does not correlate with measurements of strength and functional function. 10 However, the MQOL and SEIQOL-DW 8 have been specifically designed to subjectively assess the QOL in patients with a life-threatening illness and have not been used to assess the QOL in healthy subjects. Because we wanted to evaluate the overall QOL in patients in different stages of ALS on repeated occasions we chose to use an instrument that has also been used in healthy individuals. 11 Recently a similar method to assess QOL has been used in patients with ALS. 12 To our knowledge only one study has assessed QOL for more than 1 year in patients with ALS. In this study QOL was assessed by the MQOL for up to 16 months. 13 It is not known how QOL in patients with ALS changes over a longer period of time.
SUBJECTS AND METHODS
Twenty-six patients, attending the neurologic department at Uppsala University Hospital, 17 males and 9 females with ALS at different stages of the disease, were interviewed by one of us on one or repeated occasions. Mean age at first interview was 59.2 years (range, 44-77). The mean time from start of symptoms to the first interview was 2.1 years (range, 1-9). The characteristics of the 26 patients are presented in Table 1 . The intention was to interview patients every second time they visited us. However, some only visited us once or experienced a rapid progress and died after the first visit. The patients were diagnosed according to the El Escorial criteria 14 and clinically scored according to ALS Functioning Rating Scale (ALS FRS). 15 In this study a QOL instrument was used, which has been used by Stensman et al. since 1985. 11,16 All interviews were done at the department by one of us (I.N.), who was alone with the patient.
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The patients were asked to rate their QOL over the last 6 months on an imaginary scale from 0-10 where 0 correspond to the lowest QOL and 10 to the highest QOL. The assessment of QOL was made by the patients on the basis of their own assumptions, perceptions, goals, and values. The value of QOL was obtained from the question where the patient estimated there QOL. The aim of the other questions in the questionnaire was to find out differences between patients with different QOL.
At each interview the patients where asked to rate their QOL before onset of symptoms. The patients were also asked to answer questions according to semistructured questionnaire that included questions about medical, psychological and social factors, and motor function ( Table 2) .
Statistical methods used were Fisher's exact test, linear regression, and Wilcoxon signed rank test.
RESULTS
The mean QOL value for all 26 patients was 5.8 (0-10 point scale), which is similar to findings among 17 patients with traumatic spinal cord injury, but lower than a group of persons with pure severe disability, 8.0 and persons with no disabilities, 8.3. 11,16 Nine of the 26 patients were interviewed only once (6 males, 3 females) and the other 17 patients between 2-7 times with 4-7 months between each interview, except for 1 of the patients with a slowly progressing disease who was interviewed with longer intervals: 12 and 16 months. This gave us the possibility to follow 17 patients during 5-28 months. Nine of these patients had a follow-up time for more than 1 year. The mean QOL value for each patient is shown in Table 1 . QOL in patients interviewed more than once varied only slightly over time. The rating of 15 patients varied between 0-3 steps on the scale; the rating of only 2 patients varied 4 steps ( Table 1) . ALS FRS decreased for every patient. For 1 patient the ALS FRS values are missing because part of the medical record was lost.
All patients were divided into two groups with a mean QOL value less than 6 (n ϭ 14) or 6 or more (n ϭ 12). All variables in the questionnaire concerning medical, psychological and social factors and motor function were tested with Fisher's exact test and the two groups did not differ significantly for any of the variables.
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For the patients interviewed more than once the QOL data (n ϭ 17) and ALS FRS data (n ϭ 16) were ranked for each patient and a linear regression was made to calculate the slope of the line (b) for QOL and ALS FRS for each individual. The values for b were then tested with Wilcoxon signed rank test.
The Wilcoxon signed rank test for QOL was not significant (p ϭ 0.247), but significant (p ϭ 0.0001) for disease progression.
DISCUSSION
This is, to our knowledge, the first study where patients with ALS assessed both their present overall QOL and overall QOL before start of symptoms repeatedly for as long as up to 28 months.
The average level of QOL in our patients was similar to findings in studies using the same instrument for patients with traumatic spinal cord injury, 16 but lower than a group of persons with severe mobility disorders and persons with no disabilities. 11 The average level of QOL did not change over time in spite of worsening of the disease as measured by ALS FRS. One limitation of the statistical analyses was that the number of interviews per patient differed (Table1); for some patients with few interviews, this gave some uncertainty to the value for the slope (b) calculated with linear regression. The lack of any relation between QOL and the scores in ALS FRS supports findings from other studies, where overall QOL have been assessed. 8, 10 In our study the psychological factors seem to be of much more importance than physical disability. This is supported by the findings of Chio et al. 8 using SEIQOL-DW and MQOL where the existential domain was most important and the important factors were social support, depression and socioeconomic status and religiosity. 8 That we found no significant correlation between psychosocial factors and QOL may be because of our small material. The patients in our study did not assess their QOL before start of symptoms differently at the reassessments later in the course of the disorder. There was thus no tendency to glorify life before the symptoms started as the disease progressed. Moreover three patients did during some interviews claim higher QOL than before the period of onset of symptoms. This may be because they experienced lower level of demands both at work and at home and that they changed their priority of what was important in life.
Sweden is a country with high-priority financial security-systems for people with disabilities. The most probable reason for the differences in QOL is the differences in coping strategies among the patients and the ability of some patients to adapt to different situations. Coping in ALS is still poorly understood. Some important factors seem to be "rumination" and "hold in the religion" and as the disease progresses "search for information and communication." 17 Other factors that differ between groups of ALS patients with different QOL are optimism, flexibility and humor. 18 It can be concluded that ALS does not necessarily result in a low QOL and despite disease progression, overall QOL changes only slightly over time. To further investigate QOL over time in patients with ALS studies with larger sample size should be conducted and coping strategies better explored.
